170 related articles for article (PubMed ID: 8636012)
21. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
22. Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer.
Iino C; Shimoyama T; Sasaki Y; Sawaya M; Hanabata N; Fukuda S
Dig Endosc; 2012 Sep; 24(5):339-42. PubMed ID: 22925286
[TBL] [Abstract][Full Text] [Related]
23. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
24. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
You WC; Blot WJ; Zhang L; Kneller RW; Li JY; Jin ML; Chang YS; Zeng XR; Zhao L; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):113-7. PubMed ID: 8467245
[TBL] [Abstract][Full Text] [Related]
25. Serum pepsinogen test for early detection of gastric cancer in a European country.
Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
[TBL] [Abstract][Full Text] [Related]
26. The association of smoking and drinking habits with serum pepsinogens.
Kikuchi S; Inaba Y; Wada O; Miki K; Tenjin H; Kaneko E; Mizukoshi H
Int J Epidemiol; 1995 Apr; 24(2):346-53. PubMed ID: 7635595
[TBL] [Abstract][Full Text] [Related]
27. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
28. [A case of a gastric cancer patient with high serum pepsinogen levels at relapse].
Kimura Y; Fujii T; Miyagawa N; Tanada S; Hamamoto K; Kimura S
Gan No Rinsho; 1990 Jul; 36(8):945-8. PubMed ID: 2366328
[TBL] [Abstract][Full Text] [Related]
29. [Mass screening of gastric cancer--limits and prospects].
Yamaki G; Higashi K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1883-7. PubMed ID: 12465385
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
Miki K; Fujishiro M; Kodashima S; Yahagi N
Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
[TBL] [Abstract][Full Text] [Related]
31. O6-methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. The EUROGAST Study Group.
Carcinogenesis; 1994 Sep; 15(9):1815-20. PubMed ID: 7923573
[TBL] [Abstract][Full Text] [Related]
32. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area].
Aoki K; Misumi J
Nihon Koshu Eisei Zasshi; 1993 Apr; 40(4):313-22. PubMed ID: 8329751
[TBL] [Abstract][Full Text] [Related]
34. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
36. [Serum pepsinogen I level in patients with stomach cancer--its value and limitation in clinical use].
Miki K; Ichinose M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1122-8. PubMed ID: 2730017
[TBL] [Abstract][Full Text] [Related]
37. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.
Ohata H; Oka M; Yanaoka K; Shimizu Y; Mukoubayashi C; Mugitani K; Iwane M; Nakamura H; Tamai H; Arii K; Nakata H; Yoshimura N; Takeshita T; Miki K; Mohara O; Ichinose M
Cancer Sci; 2005 Oct; 96(10):713-20. PubMed ID: 16232204
[TBL] [Abstract][Full Text] [Related]
38. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
39. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study.
Oishi Y; Kiyohara Y; Kubo M; Tanaka K; Tanizaki Y; Ninomiya T; Doi Y; Shikata K; Yonemoto K; Shirota T; Matsumoto T; Iida M
Am J Epidemiol; 2006 Apr; 163(7):629-37. PubMed ID: 16443800
[TBL] [Abstract][Full Text] [Related]
40. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer.
Mansour-Ghanaei F; Joukar F; Baghaee M; Sepehrimanesh M; Hojati A
Biomol Concepts; 2019 May; 10(1):82-90. PubMed ID: 31188744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
